FDA ties ‘puberty-blocking’ drug to 6,379 deaths

From Free Pressers.com (Oct. 4):

More than 6,000 deaths have been linked to a puberty-blocking drug which is increasingly being given to children who claim to be transgender, the Food and Drug administration (FDA) reported.

The FDA between 2013 and June 2019 reported 41,213 adverse events, including 6,379 deaths and 25,645 “serious” reactions in patients who took Leuprolide Acetate, the hormone blocker known as Lupron.

Lupron is being used — without formal FDA approval — as a puberty blocker on an increasing number of children and adolescents who say their gender identity is not consistent with their biological sex, Breitbart News noted in an Oct. 2 report.

In 2017, AbbVie, which produces Lupron, said sales of the drug were $669 million in the United States alone.

  Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons, told Breitbart News that Lupron “is off-label for lack of long-term studies,” adding it “undoubtedly causes irreversible loss of fertility and many other adverse effects that are potentially lethal. It does not turn a male child into a female child, only into a eunuch who will lose his full potential for growth and strength. Children have no capacity to comprehend these long-term consequences, so the use of this drug in gender-confused children constitutes unethical experimentation; informed consent is not possible.” [read more]

That’s too bad.